NSE:SUNPHARMA Statistics

Total Valuation

NSE:SUNPHARMA has a market cap or net worth of INR 3.99 trillion. The enterprise value is 3.77 trillion.

Market Cap	3.99T
Enterprise Value	3.77T

Important Dates

The last earnings date was Thursday, May 22, 2025.

Earnings Date	May 22, 2025
Ex-Dividend Date	Jul 7, 2025

Share Statistics

NSE:SUNPHARMA has 2.40 billion shares outstanding. The number of shares has decreased by -0.11% in one year.

Current Share Class	2.40B
Shares Outstanding	2.40B
Shares Change (YoY)	-0.11%
Shares Change (QoQ)	-0.45%
Owned by Insiders (%)	12.01%
Owned by Institutions (%)	28.50%
Float	1.04B

Valuation Ratios

The trailing PE ratio is 36.51 and the forward PE ratio is 32.03. NSE:SUNPHARMA's PEG ratio is 2.26.

PE Ratio	36.51
Forward PE	32.03
PS Ratio	7.60
PB Ratio	5.51
P/TBV Ratio	7.36
P/FCF Ratio	33.45
P/OCF Ratio	28.39
PEG Ratio	2.26

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.02, with an EV/FCF ratio of 31.57.

EV / Earnings	34.51
EV / Sales	7.17
EV / EBITDA	25.02
EV / EBIT	30.18
EV / FCF	31.57

Financial Position

The company has a current ratio of 2.89, with a Debt / Equity ratio of 0.03.

Current Ratio	2.89
Quick Ratio	2.09
Debt / Equity	0.03
Debt / EBITDA	0.16
Debt / FCF	0.20
Interest Coverage	54.07

Financial Efficiency

Return on equity (ROE) is 15.71% and return on invested capital (ROIC) is 10.77%.

Return on Equity (ROE)	15.71%
Return on Assets (ROA)	8.81%
Return on Invested Capital (ROIC)	10.77%
Return on Capital Employed (ROCE)	16.93%
Revenue Per Employee	12.23M
Profits Per Employee	2.54M
Employee Count	43,000
Asset Turnover	0.59
Inventory Turnover	1.05

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.52% in the last 52 weeks. The beta is 0.38, so NSE:SUNPHARMA's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	+14.52%
50-Day Moving Average	1,734.52
200-Day Moving Average	1,779.05
Relative Strength Index (RSI)	40.14
Average Volume (20 Days)	3,267,763

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:SUNPHARMA had revenue of INR 525.78 billion and earned 109.29 billion in profits. Earnings per share was 45.60.

Revenue	525.78B
Gross Profit	418.31B
Operating Income	125.11B
Pretax Income	137.37B
Net Income	109.29B
EBITDA	150.86B
EBIT	125.11B
Earnings Per Share (EPS)	45.60

Full Income Statement

Balance Sheet

The company has 249.88 billion in cash and 23.62 billion in debt, giving a net cash position of 226.26 billion or 94.30 per share.

Cash & Cash Equivalents	249.88B
Total Debt	23.62B
Net Cash	226.26B
Net Cash Per Share	94.30
Equity (Book Value)	724.86B
Book Value Per Share	302.32
Working Capital	344.30B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 140.72 billion and capital expenditures -21.29 billion, giving a free cash flow of 119.44 billion.

Operating Cash Flow	140.72B
Capital Expenditures	-21.29B
Free Cash Flow	119.44B
FCF Per Share	49.78

Full Cash Flow Statement

Margins

Gross margin is 79.56%, with operating and profit margins of 23.79% and 20.79%.

Gross Margin	79.56%
Operating Margin	23.79%
Pretax Margin	26.13%
Profit Margin	20.79%
EBITDA Margin	28.69%
EBIT Margin	23.79%
FCF Margin	22.72%

Dividends & Yields

This stock pays an annual dividend of 16.00, which amounts to a dividend yield of 0.96%.

Dividend Per Share	16.00
Dividend Yield	0.96%
Dividend Growth (YoY)	18.52%
Years of Dividend Growth	6
Payout Ratio	33.07%
Buyback Yield	0.11%
Shareholder Yield	1.07%
Earnings Yield	2.74%
FCF Yield	2.99%

Dividend Details

Stock Splits

The last stock split was on July 29, 2013. It was a forward split with a ratio of 2.

Last Split Date	Jul 29, 2013
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a